Pfizer Target of Unusually High Options Trading (PFE)

Xavier Trudeau
Juin 21, 2017

Veritable Lp acquired 18,401 shares as Pfizer Inc (PFE)'s stock declined 3.45%. The institutional investor held 3.43M shares of the finance company at the end of 2016Q4, valued at $224.02 million, up from 3.20 million at the end of the previous reported quarter. Pfizer Inc now has $202.27 billion valuation. (PFE) has the trading volume of 20.3 Million shares with the average trading volume of 23410 shares.

Pfizer (NYSE:PFE) last posted its quarterly earnings results on Tuesday, May 2nd. It has underperformed by 19.46% the S&P500.The move comes after 5 months positive chart setup for the $200.53 billion company.

Onconova Therapeutics Incorporated (NASDAQ:ONTX) had an increase of 51.78% in short interest. With 184,700 avg volume, 3 days are for Onconova Therapeutics Incorporated (NASDAQ:ONTX)'s short sellers to cover ONTX's short positions. About 26,389 shares traded. (NYSE:PFE). Cypress Asset Management Tx stated it has 1.56% in Pfizer Inc. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and nine have issued a buy rating to the company's stock. Therefore 25% are positive. American International Group had 47 analyst reports since August 5, 2015 according to SRatingsIntel. (NYSE:PFE). Toronto Dominion Bankshares reported 1.15 million shares stake. Societe Generale initiated the stock with "Hold" rating in Wednesday, April 6 report. Inc. now owns 14,948 shares of the biopharmaceutical company's stock valued at $511,000 after buying an additional 250 shares during the period. The rating was initiated by Credit Suisse with "Neutral" on Friday, October 7. (NYSE:PFE) earned "Overweight" rating by Piper Jaffray on Friday, August 28. The fund owned 98,337 shares of the biopharmaceutical company's stock after selling 2,005 shares during the period. The firm earned "Hold" rating on Wednesday, November 2 by Argus Research. Newman Dignan & Sheerar Inc bought 4,245 shares as the company's stock rose 10.23% with the market. "(NYSE:PFE) news were published by: " which released: "Better Buy: "Pfizer Inc. vs. Johnson & Johnson" on June 08, 2017, also with their article: "(tofacitinib citrate) ORAL Strategy Study Published in The Lancet and ..." published on June 16, 2017, published: "Pfizer shrugs off potential ire from politicians; hikes prices 20%" on June 02, 2017. Barclays PLC set a $38.00 price objective on shares of Pfizer and gave the stock a "buy" rating in a research note on Thursday, March 16th. Its up 0.03, from 0.58 in 2016Q3. It turned negative, as 60 investors sold PFE shares while 672 reduced holdings.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Ngam Advisors Limited Partnership reported 0.48% stake. Orrstown Financial Services Inc. now owns 3,275 shares of the biopharmaceutical company's stock valued at $112,000 after buying an additional 612 shares during the period. Webster National Bank N A has invested 0.82% of its portfolio in Pfizer Inc. (PFE) now has a value of $33.22 while the company's 52 week low is at $29.83, the shares dropped to the 52 week low on 11/03/16. Bainco International Investors boosted its stake in Pfizer by 1.3% in the third quarter. (PFE) is its Earnings per Share or EPS. Laurel Grove Limited Liability Corp invested in 23,550 shares. Cg Asset Management Llc holds 22,365 shares or 0.27% of its portfolio. Financial Bank Of The Ozarks reported 0.63% in Pfizer Inc. (NYSE:PFE). Interocean Ltd Liability accumulated 0.07% or 9,524 shares. Zeke Capital Advisors Ltd Liability Co invested in 45,733 shares. London Of Virginia, a Virginia-based fund reported 6.64M shares. Hanson Mcclain accumulated 13,709 shares. Ontario Teachers Pension Plan Board invested in 0.44% or 1.28M shares. Bancshares owns 65,451 shares for 0.94% of their portfolio.

Since February 27, 2017, it had 0 insider purchases, and 5 insider sales for $5.16 million activity. Dolsten Mikael sold $1.07 million worth of stock or 30,970 shares. $1.23M worth of Pfizer Inc. LANKLER DOUGLAS M had sold 20,000 shares worth $693,200. had 24 analyst reports since August 4, 2015 according to SRatingsIntel. (NYSE:PFE). First Amer Natl Bank reported 182,129 shares. The company's revenue for the quarter was down 1.7% on a year-over-year basis. PFE's profit would be $3.90 billion giving it 12.86 P/E if the $0.65 EPS is correct. Buffington Mohr Mcneal has invested 0.14% of its portfolio in Pfizer Inc. The company has market cap of $20.59 million.

Immersion Corporation is a licensing firm focused on the creation, design, development and licensing of haptic technologies that allow people to use their sense of touch when operating digital devices.

Stock is now moving with a positive distance from the 200 day simple moving average of approximately 0.73%, and has a solid year to date (YTD) performance of 2.28% which means the stock is constantly adding to its value from the previous fiscal year end price.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

D'autres rapports CampDesrEcrues

Discuter de cet article